Article | December 14, 2023

A CDMO's Mission To Empower Emerging Biotechs

By Jeff Wolf, Founder and Executive Chairman, Scorpius BioManufacturing


As global demand for biologics manufacturing capacity continues to rise, finding a CDMO that treats you as a partner and takes small programs seriously is crucial. Personal attention, responsiveness, quality, flexibility and ease of communication should be table stakes in any biomanufacturing partnership.

However, drug sponsor companies with small-volume programs can often end up spending massive amounts of money on manufacturing without getting the required attention from a manufacturing partner.

Scorpius BioManufacturing emerged from the growing need for a CDMO that prioritized and valued small-volume clients. We seek to support and empower sponsors with our caring and open approach and build a true partnership in which we treat our partners’ products as our own. We created capacity; but, more importantly, we addressed the need for a better model to help our partners advance their smaller biologic programs to the clinic and beyond.

Learn a CDMO that respects and tailors services to the unique manufacturing needs of early-stage companies and small-scale programs is promoting innovation in the industry and modelling what true partnership should look like.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma